Antimicrobial drug resistance in Taiwan

International Journal of Antimicrobial Agents - Tập 32 - Trang S174-S178 - 2008
Yu-Tsung Huang1, Po-Ren Hsueh1
1Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

Tài liệu tham khảo

Song, 2004, High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolate in Asia (an ANSORP study), Antimicrob Agents Chemother, 48, 2101, 10.1128/AAC.48.6.2101-2107.2004 Hsueh, 2005, Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan, Clin Microbiol Infect, 11, 925, 10.1111/j.1469-0691.2005.01245.x Tristram, 2007, Antimicrobial resistance in Haemophilus influenzae, Clin Microbiol Rev, 20, 368, 10.1128/CMR.00040-06 Hotomi, 2007, Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan, Antimicrob Agents Chemother, 51, 3969, 10.1128/AAC.00422-07 Hsueh, 2000, Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998–1999 respiratory season, Antimicrob Agents Chemother, 44, 1342, 10.1128/AAC.44.5.1342-1345.2000 Hoban, 2002, The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections, J Antimicrob Chemother, 50, 49, 10.1093/jac/dkf810 Cantón, 2002, Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999–2000, J Antimicrob Chemother, 50, 9, 10.1093/jac/dkf811 Hsueh, 2003, Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes : SMART Program 2001 Data, Antimicrob Agents Chemother, 47, 2152, 10.1128/AAC.47.7.2152-2157.2003 Beekmann, 2005, Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002–2003. Results of the multinational GRASP Surveillance Program, Int J Antimicrob Agents, 25, 148, 10.1016/j.ijantimicag.2004.09.016 Chang, 1995, Macrolides resistance of common bacteria isolated from Taiwan, Diagn Microbiol Infect Dis, 23, 147, 10.1016/0732-8893(95)00197-2 Hsueh, 1995, Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan, Antimicrob Agents Chemother, 39, 2239, 10.1128/AAC.39.10.2239 Hsueh, 2005, Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococ- cus pyogenes in Taiwan, Clin Infect Dis, 40, 903, 10.1086/427946 Chiu, 2002, The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, N Engl J Med, 346, 413, 10.1056/NEJMoa012261 Chiu, 2004, Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment, Clin Microbiol Rev, 17, 311, 10.1128/CMR.17.2.311-322.2004 Hsueh, 2004, Ciprofloxacin- resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan, Emerg Infect Dis, 10, 60, 10.3201/eid1001.030171 Yan, 2005, Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan, Emerg Infect Dis, 11, 947, 10.3201/eid1106.041153 Boucher, 2008, Epidemiology of methicillin-resistant Staphylococcus aureus, Clin Infect Dis, 46, S344, 10.1086/533590 Wu, 2002, Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors, J Microbiol Immunol Infect, 35, 53 Boyle-Vavra, 2005, Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV, J Clin Microbiol, 43, 4719, 10.1128/JCM.43.9.4719-4730.2005 Matsumoto, 2008, Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae, Int J Antimicrob Agents, 31, S35, 10.1016/j.ijantimicag.2007.08.029 Hsueh, 2005, High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan, Clin Infect Dis, 40, 188, 10.1086/426142 Su, 2007, Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999–2006, Sex Transm Dis, 34, 995, 10.1097/OLQ.0b013e3180ca8f24 Bala, 2008, Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrhoeae in India, Sex Transm Dis, 35, 588, 10.1097/OLQ.0b013e3181666ac8 Clinical and Laboratory Standards Institute, 2008 Hirakata, 2005, Regional variation in the prevalence of extended-spectrum beta-lactamase- producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002), Diagn Microbiol Infect Dis, 52, 323, 10.1016/j.diagmicrobio.2005.04.004 Paterson, 2005, Extended-spectrum beta-lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005 Hawkey, 2008, Prevalence and clonality of extended-spectrum beta-lactamases in Asia, Clin Microbiol Infect, 14, 159, 10.1111/j.1469-0691.2007.01855.x Yu, 2006, Extended-spectrum beta- lactamases in Taiwan: epidemiology, detection, treatment and infection control, J Microbiol Immunol Infect, 39, 264 Hsueh, 2002, Current status of antimicrobial resistance in Taiwan, Emerg Infect Dis, 8, 132, 10.3201/eid0802.010244 Hadadi, 2008, Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran, Diagn Microbiol Infect Dis, 60, 301, 10.1016/j.diagmicrobio.2007.10.010 Ishii, 2008, Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006, Diagn Microbiol Infect Dis, 61, 346, 10.1016/j.diagmicrobio.2008.01.022 Walsh, 2005, Metallo-beta-lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005 Yan, 2001, Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme, Antimicrob Agents Chemother, 45, 2224, 10.1128/AAC.45.8.2224-2228.2001 Huang, 2007, Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan, Diagn Microbiol Infect Dis, 59, 211, 10.1016/j.diagmicrobio.2007.01.009 Yu, 2006, Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals, J Clin Microbiol, 44, 4242, 10.1128/JCM.01558-06 Dijkshoorn, 2007, An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii, Nat Rev Microbiol, 5, 939, 10.1038/nrmicro1789 Reinert, 2007, Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline, J Antimicrob Chemother, 60, 1018, 10.1093/jac/dkm310 Kuo, 2008, Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study, Int J Antimicrob Agents, 31, 420, 10.1016/j.ijantimicag.2008.01.010 Hsueh, 2004, Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001, Antimicrob Agents Chemother, 48, 1361, 10.1128/AAC.48.4.1361-1364.2004 Hsueh, 2005, Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents, Int J Antimicrob Agents, 26, 43, 10.1016/j.ijantimicag.2005.04.007 Luh, 2000, Quinupristin- dalfopristin resistance among Gram-positive bacteria in Taiwan, Antimicrob Agents Chemother, 44, 3374, 10.1128/AAC.44.12.3374-3380.2000 Biedenbach, 2007, Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003–2004), Int J Antimicrob Agents, 30, 143, 10.1016/j.ijantimicag.2007.03.015 Hiramatsu, 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin, Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8 Kim, 2004, In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary- care hospitals in Korea: a nationwide survey, Antimicrob Agents Chemother, 48, 1124, 10.1128/AAC.48.4.1124-1127.2004 Trakulsomboon, 2001, First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand, J Clin Microbiol, 39, 591, 10.1128/JCM.39.2.591-595.2001 Wang, 2004, Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan, Emerg Infect Dis, 10, 1702, 10.3201/eid1009.040239 Song, 2004, Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin, Antimicrob Agents Chemother, 48, 4926, 10.1128/AAC.48.12.4926-4928.2004 Hsueh, 2001, Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan, Microb Drug Resist, 7, 345, 10.1089/10766290152773383 Lu, 2001, High prevalence of vanB2 vancomycin resistant Enterococcus faecium in Taiwan, J Clin Microbiol, 39, 2140, 10.1128/JCM.39.6.2140-2145.2001 Hsueh, 2006, Mycobacterium tuberculosis in Taiwan, J Infect, 52, 77, 10.1016/j.jinf.2005.08.008 Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan. Clin Infect Dis. Forthcoming 2008. Pfaller, 2007, Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing, J Clin Microbiol, 45, 1735, 10.1128/JCM.00409-07 Hsueh, 2005, Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003, Antimicrob Agents Chemother, 49, 512, 10.1128/AAC.49.2.512-517.2005 Ruan, 2008, In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible- dose dependent Candida glabrata isolates, Antimicrob Agents Chemother, 52, 2919, 10.1128/AAC.00323-08